Classical Vaidya Regulation ↔ NCISM Act, Drugs & Cosmetics Act and Drugs & Magic Remedies Act
Classical practice was regulated through guru-shishya lineage and textual authority; today the NCISM Act, Drugs and Cosmetics Act, and Drugs and Magic Remedies Act together define who may practice, what may be sold, and what may lawfully be claimed.
IN PLAIN LANGUAGE
Ayurvedic practitioners and medicines are regulated by specific modern laws — a national council registers practitioners, a drugs act licenses and labels the medicines, and a separate law makes it illegal to advertise 'cures' for many conditions.
Modern law gives you a way to verify a practitioner's registration and a medicine's legal safety labeling; the classical tradition offers the underlying pharmacological knowledge, such as recognizing upavisha toxic substances, that this regulation was built on.
WHEN TO SEEK CARE
If a product or practitioner claims to 'cure' a serious condition, or a poisonous-substance medicine isn't labeled with the required caution, treat that as a warning sign and verify registration and licensing before proceeding.
🔴 REFER IMMEDIATELY
- Advertising or claiming to 'cure' any condition listed under the DMR Act schedule
- Dispensing Schedule E(1) poisonous ASU substances without the mandated caution label or proper shodhana
- Citing the CCIM as the current regulatory authority
- Verify current NCISM registration before practicing or supervising trainees
- Refer any suspected illegal cure-claim advertising for regulatory or legal review
Never do this
Never advertise or publish a claim that an Ayurvedic treatment 'cures' a condition listed under the Drugs and Magic Remedies Act schedule — this is a criminal offence, not just an ethical lapse.
🟢 SUITABLE FOR ROUTINE / COLLABORATIVE CARE
AYURVEDA SCOPE
Manufacturing, labeling and dispensing ASU medicines, including Schedule E(1) substances, when properly purified, licensed and labeled under the Drugs and Cosmetics Rules.
MODERN MEDICINE SCOPE
Registration, disciplinary action and professional standard-setting for Indian-system practitioners now sits exclusively with the NCISM, not the defunct CCIM.
COLLABORATIVE SCOPE
Practitioners and platforms should describe treatment benefits only in terms lawful under the DMR Act, avoiding cure-claims for its scheduled conditions.
Sign in to read the full comparison
The plain-language summary and safety guidance above are free for everyone. The 10-dimension scholarly comparison needs an account.
Sign in